Clinical Trials on Graft Loss

Total 5998 results

Universidad Complutense de Madrid

Completed

Factors Influencing Bone Block Allograft Resorption

Graft Loss
Leiden University Medical Center

Completed

Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients (Neptune)

Rejection | Graft Loss

Netherlands
University Hospital, Basel, Switzerland
Clinical Trial Unit, University Hospital Basel, Switzerland; Ospedale Regionale...

Recruiting

Recipient Site Pre-conditioning in Fat Grafting (me15Schaefer)

Condition | Graft Loss

Switzerland
fang guofang

Unknown

Clinical Application of Personal Designed 3D Printing Implants in Bone Defect Restoration

Defect; Internal Prosthetic Device, Implants and Grafts, Orthopedic, Bone Graft

China
Paris Translational Research Center for Organ Transplantation

Unknown

Long-term Outcomes After Conversion to Belatacept

Immunosuppression | Kidney Transplant Failure and Rejection | Drug Effect Prolonged | Graft Loss
Cairo University

Completed

Effect of Customized Healing Abutment on Soft Tissue Alterations Around Immediate Implant Placements With or Without Bone Graft Versus Connective Tissue Graft

Customized Healing Abutment Bone Grafts Connective Tissue Graft Immediate Implant Placement

Egypt
Istanbul University

Completed

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Kidney Transplant Rejection | Antibody-mediated Rejection | Graft Loss

Turkey
Universitaire Ziekenhuizen KU Leuven

Completed

Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients

Acute Rejection of Renal Transplant | Renal Graft Loss

Belgium
Ruijin Hospital
Chugai Pharma China

Completed

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts (ASRAB-Pilot)

Coronary Artery Bypass Graft | Radial Artery Grafts | Antispastic Therapy | Pilot Study

China
Federal University of São Paulo

Suspended

Graft Take and Microbiology in Burns

Burns | Transplantation Infection | Infection | Wound of Skin | Graft Loss
Michael Bezuhly

Unknown

Effect of N-Acetylcysteine on Autologous Fat Graft Survival

Adipose Tissue Atrophy | Graft Loss | Deformity of Reconstructed Breast
University of Bern

Recruiting

Patient-reported Outcome Measures After Implant Placement With Contour Augmentation Procedure

Tooth Loss | Patient Satisfaction | Patient Acceptance of Health Care | Bone Graft; Complications

Switzerland
Federico II University

Completed

Posterior CAD/CAM Cobalt-chromium Alloy Single Crowns: 4-year Prospective Clinical Study

Single Tooth Lost
University of Liege

Terminated

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Chronic Graft-Versus-Host Disease | Acute Graft-Versus-Host Disease | Steroid Refractory Graft-Versus-Host Disease

Belgium
Jazz Pharmaceuticals

Completed

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Acute-graft-versus-host Disease | Graft-versus-host Disease

United States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
Centre of Postgraduate Medical Education

Unknown

The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction

Adipose Tissue Atrophy | Breast; Deformity, Congenital | Graft Loss | Breast; Atrophy

Poland
National Cancer Institute (NCI)

Terminated

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Graft vs Host Disease | Graft-Versus-Host Disease | Chronic Graft vs. Host Disease

United States
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. (CSM/EICH2010)

Chronic Graft-Versus-Host Disease

Spain
Cairo University

Unknown

Patient Satisfaction and Bone Gain Following Autogenous Particulate Sticky Bone Preparation With Xenograft Versus Without Xenograft for Grafting of Maxillary Anterior Knife Edge Ridge in Partially Edentulous Patients for Implant Placement

Alveolar Bone Loss | Bone Graft; Complications

Egypt
Washington University School of Medicine

Completed

Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation

Graft Vs Host Disease | Graft-versus-host-disease

United States
Regimmune Corporation

Completed

RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

Graft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHD

United States
Mesoblast, Inc.
Quintiles, Inc.

Completed

Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

Grade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host Disease

United States
Fundación Pública Andaluza para la gestión de la...
Instituto de Salud Carlos III

Active, not recruiting

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant (AlloBolome)

Graft-versus-host Disease

Spain
Children's Hospital Medical Center, Cincinnati

Completed

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

Graft Vs Host Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Graft-Versus-Host Disease

United States
Mallinckrodt

Completed

Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

Graft-versus-Host Disease

United States, Australia, France, Italy, Austria, Germany, Portugal, Slovakia, Spain, Switzerland, Turkey, United Kingdom
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

Graft-versus-Host Disease

United States
Abgenix
Sangstat Medical Corporation

Completed

Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease

Graft Vs Host Disease

United States
Shenzhen University General Hospital

Recruiting

Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease

Graft Vs Host Disease

China
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)

Graft-Versus-Host Disease

United States
M.D. Anderson Cancer Center

Completed

Experience of Having Chronic Graft-Versus-Host Disease

Graft-Versus-Host Disease

United States
John Levine

Completed

Itacitinib for Low Risk GVHD

GVHD | Low Risk Acute Graft-versus-host Disease | Graft-versus-host-disease

United States
Rambam Health Care Campus

Withdrawn

Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host Disease

Fecal Microbiota Transplantation in Graft vs. Host Disease

Israel
Rabin Medical Center

Unknown

Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease (GVHD)

Graft Vs Host Disease

Israel
Karolinska Institutet
Region Stockholm

Terminated

Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease

Graft-Versus-Host Disease

Sweden
Ohio State University Comprehensive Cancer Center

Completed

Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease

Graft-Versus-Host Disease

United States
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease

Graft-Versus-Host Disease

United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Not yet recruiting

A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Acute Graft-Versus-Host Disease

China
ASC Therapeutics

Not yet recruiting

ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

Acute-graft-versus-host Disease
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Xinqiao Hospital...

Recruiting

MSC for Treatment of cGVHD After Allo-HSCT

Chronic Graft-versus-host Disease

China
The First Affiliated Hospital of Soochow University

Recruiting

Fecal Microbiota Transplantation in Gut aGVHD Treated

Acute-graft-versus-host Disease

China
Navy General Hospital, Beijing

Recruiting

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Chronic Graft-versus-host Disease

China
Genentech, Inc.

Completed

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Acute Graft-versus-host Disease

United States
Genentech, Inc.

Terminated

A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

Acute Graft-versus-host Disease

United States, Canada
Incyte Corporation

Completed

A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Graft-versus-host Disease (GVHD)

United States
Incyte Corporation

Completed

GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

Graft-versus-host Disease (GVHD)

United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics

Graft-versus-host Disease Prevention

United States
Incyte Corporation

Completed

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Graft-versus-host Disease (GVHD)

United States
Northside Hospital, Inc.
Blood and Marrow Transplant Group of Georgia

Completed

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Chronic Graft-versus-host Disease

United States
Guangdong Provincial People's Hospital
Sun Yat-sen University; Guangzhou First People's Hospital; Nanfang Hospital of... and other collaborators

Unknown

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells (MSC-cGvHD)

Chronic Graft-Versus-Host Disease

China

Clinical Trials on Graft Loss

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations